Literature DB >> 12716758

Increased expression of ornithine decarboxylase in distal tubules of early diabetic rat kidneys: are polyamines paracrine hypertrophic factors?

Aihua Deng1, Karen A Munger, Jose M Valdivielso, Joseph Satriano, Mark Lortie, Roland C Blantz, Scott C Thomson.   

Abstract

Polyamines are small biogenic molecules that are essential for cell cycle entry and progression and proliferation. They can also contribute to hypertrophy. The activity of ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis, increases in the early diabetic kidney to enable renal hypertrophy. Inhibition of ODC in early diabetes attenuates diabetic renal hypertrophy and glomerular hyperfiltration. The current studies examine the temporal profile of renal ODC protein expression and localization, intrarenal polyamine levels, and sites of proliferation in kidneys of rats during the first 7 days of streptozotocin diabetes. ODC mRNA and protein content were increased in diabetic kidneys. High-performance liquid chromatography analysis showed increased intrarenal polyamine concentrations peaking after 24 h of diabetes. A subsequent increase in the number of proliferating proximal tubular cells was detected by in vivo 5-bromodeoxyuridine (BrdU) incorporation on day 3. Surprisingly, immunohistochemical studies revealed that increased ODC protein was apparent only in distal nephrons, whereas the main site of diabetic kidney hypertrophy is the proximal tubule. These findings raise the possibility that polyamines produced in the distal nephron may mediate the early diabetic kidney growth of the proximal tubules via a paracrine mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716758     DOI: 10.2337/diabetes.52.5.1235

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.

Authors:  Eva Parisi; Milica Bozic; Mercé Ibarz; Sara Panizo; Petya Valcheva; Blai Coll; Elvira Fernández; José M Valdivielso
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

2.  Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes.

Authors:  Joseph Satriano; Hadi Mansoury; Aihua Deng; Kumar Sharma; Volker Vallon; Roland C Blantz; Scott C Thomson
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

Review 3.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 4.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

Review 5.  The proximal tubule in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-12       Impact factor: 3.619

Review 6.  Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Annu Rev Physiol       Date:  2012       Impact factor: 19.318

7.  Ornithine decarboxylase inhibitor eliminates hyperresponsiveness of the early diabetic proximal tubule to dietary salt.

Authors:  Cynthia M Miracle; Timo Rieg; Hadi Mansoury; Volker Vallon; Scott C Thomson
Journal:  Am J Physiol Renal Physiol       Date:  2008-06-18

8.  Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus.

Authors:  Volker Vallon; Michael Rose; Maria Gerasimova; Joseph Satriano; Kenneth A Platt; Hermann Koepsell; Robyn Cunard; Kumar Sharma; Scott C Thomson; Timo Rieg
Journal:  Am J Physiol Renal Physiol       Date:  2012-11-14

9.  Critical factors determining dimerization of human antizyme inhibitor.

Authors:  Kuo-Liang Su; Ya-Fan Liao; Hui-Chih Hung; Guang-Yaw Liu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 10.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.